Cancer trials suspended for new patients
Beth Israel Deaconess Medical Center temporarily closed all its cancer trials to new patients last week, after audits found that several researchers had not properly submitted patient data to the committee that oversees oncology research and to trial sponsors.
“Some of our clinical trials were not running with the high standards that we expect,’’ Randy Mason, vice president of research operations, wrote in an e-mail to hospital executives and physician leaders last week.
He described the lapses as involving documentation and reporting compliance and said the hospital has not found any “issues of patient harm.’’
- As Medicare Advantage Cuts Loom, Disagreement Over Program's Stability
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- 3 Management Lessons from a Supermarket Debacle
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- Centralizing the Revenue Cycle Protects the Bottom Line
- CA Fines 8 Hospitals for Medical Errors
- Revenue Cycles Get a Boost from Simple JPEG Files
- Doctors Feel Pressure to Accept Risk-based Reimbursement
- Employers Weigh Risks, Benefits of Private Exchanges
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows